TransMedics Group Gross Margin Growth & History (TMDX)
TransMedics Group's gross margin was 59.92% for fiscal 2025.
View full TransMedics Group company overviewTransMedics Group annual gross margin history
2018
2019
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 59.92% | +0.56 pp |
| 2024 | 2024-12-31 | 59.36% | −4.42 pp |
| 2023 | 2023-12-31 | 63.77% | −6.07 pp |
| 2022 | 2022-12-31 | 69.84% | +2.42 pp |
| 2021 | 2021-12-31 | 67.42% | +8.75 pp |
| 2020 | 2020-12-31 | 58.66% | +5.02 pp |
| 2019 | 2019-12-28 | 53.64% | +14.52 pp |
| 2018 | 2018-12-29 | 39.12% | — |
TransMedics Group quarterly gross margin
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 59.59% | −1.78 pp |
| Q1 2026 | 2026-03-31 | 58.16% | −3.31 pp |
| Q4 2025 | 2025-12-31 | 58.11% | −1.10 pp |
| Q3 2025 | 2025-09-30 | 58.80% | +2.86 pp |
| Q2 2025 | 2025-06-30 | 61.38% | +0.78 pp |
| Q1 2025 | 2025-03-31 | 61.47% | −0.45 pp |
| Q4 2024 | 2024-12-31 | 59.21% | +0.17 pp |
| Q3 2024 | 2024-09-30 | 55.94% | −5.27 pp |
| Q2 2024 | 2024-06-30 | 60.59% | −9.44 pp |
| Q1 2024 | 2024-03-31 | 61.91% | −7.31 pp |
| Q4 2023 | 2023-12-31 | 59.04% | −4.17 pp |
| Q3 2023 | 2023-09-30 | 61.21% | −13.33 pp |
| Q2 2023 | 2023-06-30 | 70.03% | +0.10 pp |
| Q1 2023 | 2023-03-31 | 69.23% | −7.00 pp |
| Q4 2022 | 2022-12-31 | 63.21% | −9.05 pp |
| Q3 2022 | 2022-09-30 | 74.54% | +4.84 pp |
| Q2 2022 | 2022-06-30 | 69.93% | +5.44 pp |
| Q1 2022 | 2022-03-31 | 76.22% | +13.23 pp |
| Q4 2021 | 2021-12-31 | 72.26% | +8.96 pp |
| Q3 2021 | 2021-09-30 | 69.70% | +6.51 pp |
| Q2 2021 | 2021-06-30 | 64.49% | +15.82 pp |
| Q1 2021 | 2021-03-31 | 63.00% | +4.04 pp |
| Q4 2020 | 2020-12-31 | 63.30% | +1.54 pp |
| Q3 2020 | 2020-09-30 | 63.19% | +9.66 pp |
| Q2 2020 | 2020-06-30 | 48.66% | −4.97 pp |
| Q1 2020 | 2020-03-31 | 58.96% | +10.32 pp |
| Q4 2019 | 2019-12-28 | 61.76% | +19.47 pp |
| Q3 2019 | 2019-09-28 | 53.53% | +8.69 pp |
| Q2 2019 | 2019-06-29 | 53.63% | +17.51 pp |
| Q1 2019 · Mar 30 | 2019-03-30 | 48.64% | +15.11 pp |
| Q4 2018 | 2018-12-29 | 42.30% | — |
| Q3 2018 | 2018-09-29 | 44.84% | — |
| Q2 2018 | 2018-06-30 | 36.12% | — |
| Q1 2018 | 2018-03-31 | 33.53% | — |
TransMedics Group gross margin trends
Over the last five fiscal years, TransMedics Group's gross margin increased from 58.66% to 59.92%, a change of +1.25 percentage points. The latest reported quarter, Q2 2026, shows 59.59%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TransMedics Group source filings ↗